AZB & Partners advised the Board of JB Chemicals and Pharmaceuticals in Torrent Pharma’s acquisition and proposed merger
AZB & Partners represented the Board of JB Chemicals and Pharmaceuticals Limited (“JB Pharma”) in relation to Torrent Pharmaceuticals Limited’s (“Torrent Pharma”) acquisition of a 46.39% equity stake in JB Pharma from global investment firm KKR. The transaction values JB Pharma at an equity valuation of INR 25,689 crores on a fully diluted basis.
The deal also includes an open offer by Torrent Pharma to acquire up to 26% of the equity shares of JB Pharma from its public shareholders, in accordance with SEBI Takeover Regulations. Subsequently, a merger of JB Pharma into Torrent Pharma has been proposed through a scheme of arrangement.
This strategic acquisition and merger aim to create synergies across product portfolios, strengthen market presence, and drive long-term growth in the pharmaceutical sector.
The AZB & Partners team was led by Vaidhyanadhan Iyer (Senior Partner), Jeet Chaudhuri (Partner), and Himanshoo Tembe (Counsel), with support from Sana Nagar (Senior Associate) and Priya Venkatesan, Abhinav Shankarraman, and Akanksha Khandelwal (Associates).
Click to know more about AZB & Partners
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at [email protected] or call us on +91 8879634922.